Description
Recombinant monoclonal antibody to CD80. Manufactured using AbAb’s Recombinant Platform with variable regions (i.e. specificity) from the hybridoma RM80. This chimeric mouse antibody was made using the variable domain sequences of the original Rat IgG2a format, for improved compatibility with existing reagents, assays and techniques.
Target
CD80
Target Alias Names
B7-1, Activation B7-1 antigen, B7, B7 protein, B7-1 protein, B7.1, Cd28l, CD28LG, CD28LG1, LAB7, Ly-53, Ly53, MIC17, T-cell co-stimulatory protein B7-1, T-lymphocyte activation antigen CD80, TS/A-1
Isotype/Mimetic
IgG2b
Animal-Derived Biomaterials Used
No
Sequence Available
No
Original Discovery Method
recombinantly reformatted hybridoma (from pre-2020 immunisation)
Original Discovery Information Provided On Datasheet
Yes
Antibody/Binder Origins
Animal-dependent discovery (in vitro display, OR immunisation pre-2020), In vitro recombinant expression